Xalud Therapeutics’ Lead Candidate, XT-150, Achieves Multiple Clinical Milestones in Pathologic Inflammation and Neuroimmunology Therapeutic Areas

Xalud Therapeutics’ Lead Candidate, XT-150, Achieves Multiple Clinical Milestones in Pathologic Inflammation and Neuroimmunology Therapeutic Areas

Completion of enrollment for the Phase 2b study in osteoarthritis of the knee Clinical data presented at OARSI provides support for osteoarthritis program First patient dosed in the Phase 1/2a study in neuropathic pain NEW YORK–(BUSINESS WIRE)–Xalud Therapeutics, a clinical-stage biotechnology company developing novel non-viral gene therapies to treat pathologic inflammation through immune modulation, today […]

Chef Demonstration and Wine Pairing with Rocca Family Vineyards

Join us virtually, relax and enjoy a live cooking demonstration of Hawaiian culinary delights paired with Rocca Family Vineyards wines. Chef Tom Wong, a talented chef from the Culinary Institute of America, will prepare a tantalizing dinner including traditional Hawaiian ingredients, methods, and colorful stories. Wines have been selected by Rocca Winemaker, Paul Colantuoni, matched perfectly with each […]